Nektar Therapeutics (NKTR) Total Debt Growth (3y) (2014 - 2020)
Nektar Therapeutics (NKTR) Total Debt Growth (3y) (2014 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 50.25% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 25.25% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Nektar Therapeutics | 1.76 Bn | 1.19 Bn | 3.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 27.79% |
| Dec 31, 2019 | 1.27% |
| Sep 30, 2019 | 0.72% |
| Jun 30, 2019 | 0.72% |
| Mar 31, 2019 | 0.72% |
| Dec 31, 2018 | 0.72% |
| Sep 30, 2018 | 25.40% |
| Jun 30, 2018 | 25.33% |
| Mar 31, 2018 | 25.26% |
| Dec 31, 2017 | 25.18% |
| Sep 30, 2017 | 25.11% |
| Jun 30, 2017 | 25.03% |
| Mar 31, 2017 | 24.96% |
| Dec 31, 2016 | 24.88% |
| Sep 30, 2016 | 24.81% |
| Jun 30, 2016 | 24.73% |
| Mar 31, 2016 | 24.66% |
| Dec 31, 2015 | 24.58% |
| Sep 30, 2015 | 0.00% |
| Mar 31, 2015 | -16.53% |